Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease

Transfusion

Volumn 55, Issue 6, 2015, Pages 1399-1406

  Karafin, Matthew S ^a   Field, Joshua J ^a   Gottschall, Jerome L ^a,b   Denomme, Gregory A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIGEN; BLOOD GROUP ANTIGEN;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; RECIPIENT; SICKLE CELL ANEMIA; AGED; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; BLOOD; COMMUNICATION DISORDER; ERYTHROCYTE; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MIDDLE AGED; MOLECULAR TYPING; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; BLOOD DONORS; BLOOD GROUP ANTIGENS; COMMUNICATION BARRIERS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; MOLECULAR TYPING; YOUNG ADULT;

EID: 84931567110     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13037     Document Type: Article

References (36)

1. Smith-Whitley K, Thompson AA,. Indications and complications of transfusions in sickle cell disease. Pediatr Blood Cancer 2012; 59: 358-64.
2. Issit PD, Anstee DJ., Applied blood group serology. 4th ed. Durham (NC): Montgomery Scientific; 1998. p. 873-5.
3. Zalpuri S, Zwaginga JJ, le Cessie S, et al., Red blood cell alloimmunization and number of red blood cell transfusions. Vox Sang 2012; 102: 144-9.
4. Treml A, King KE,. Red blood cell alloimmunization: lessons from sickle cell disease. Transfusion 2013; 53: 692-5.
5. Sarnaik S, Schornack J, Lusher JM,. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986; 26: 249-52.
6. Orlina AR, Unger PJ, Koshy M,. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978; 5: 101-6.
7. Rosse WF, Gallagher D, Kinney TR, et al., Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76: 1431-7.
8. Vichinsky EP, Earles A, Johnson RA, et al., Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-21.
9. Aygun B, Padmanabhan S, Paley C, et al., Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who receive transfusions. Transfusion 2002; 42: 37-43.
10. Cox JV, Steane E, Cunningham G, et al., Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485-9.
11. de Montalembert M, Dumont MD, Heilbronner C, et al., Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011; 96: 801-7.
12. Talano JA, Hillary CA, Gottschall JL, et al., Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003; 111: e661-5.
13. Garratty G,. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997; 37: 357-61.
14. King KE, Shirey RD, Lankiewicz MW, et al., Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997; 37: 376-81.
15. Petz LD, Calhoun L, Shulman IA, et al., The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 382-92.
16. Tahhan HR, Holbrook CT, Braddy LR, et al., Antigen-matched donor blood in the transfusion management of patients with sickle. Transfusion 1994; 34: 562-9.
17. Vichinsky EP, Luban NL, Wright E, et al., Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multi-center transfusion trial. Transfusion 2001; 41: 1086-92.
18. Castro O, Sandler SG, Houston-Yu P, et al., Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42: 684-90.
19. Lasalle-Williams M, Nuss R, Le T, et al., Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011; 51: 1732-9.
20. Reid ME, Lomas-Francis C, Olsson ML., The blood group antigen facts book. 3rd ed. London: Elsevier; 2012.
21. Chou ST, Jackson T, Vege S, et al., High prevalence of red cell alloimmunization in sickle cell disease despite transfusion from Rh matched minority donors. Blood 2013; 122: 1062-71.
22. Hopp K, Weber K, Bellissimo D, et al., High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010; 50: 40-6.
23. Faas BH, Beckers EA, Wildoer P, et al., Molecular background of VS and weak C expression in blacks. Transfusion 1997; 37: 38-44.
24. Daniels GL, Faas BH, Green CA, et al., The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998; 38: 951-8.
25. Noizat-Pirenne F, Mouro I, Le Pennec PY, et al., Two new alleles of the RHCE gene in black individuals: the RHce allele ceMO and the RHcE allele cEMI. Br J Haematol 2001; 113: 672-9.
26. Noizat-Pirenne F, Lee K, Pennec PY, et al., Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002; 100: 4223-31.
27. Storry JR, Reid ME, Fetics S, et al., Mutations in GYPB exon 5 drive the S-s-U+(var) phenotype in persons of African descent: implications for transfusion. Transfusion 2003; 43: 1738-47.
28. O'Suoji C, Liem RI, Mack AK, et al., Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer 2013; 60: 1487-91.
29. Venkateswaran L, Teruya J, Bustillos C, et al., Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer 2011; 57: 294-6.
30. Miller ST, Kim HY, Weiner DL, et al., Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Red blood cell alloimmunization in sickle cell disease: prevalence in 2013. Transfusion 2013; 53: 704-9.
31. Natukunda B, Schonewille H, Ndugwa C, et al., Red blood cell alloimmunization in sickle disease patients in Uganda. Transfusion 2010; 50: 20-5.
32. James AB, Hillyer CD, Shaz BH,. Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion 2012; 52: 1050-61.
33. Shaz BH, James AB, Hillyer KL, et al., Demographic variation in blood donor deferrals in a major metropolitan area. Transfusion 2010; 50: 881-7.
34. James AB, Demmons DG, Schreiber GB, et al., Contribution of attitudinal factors to blood donation in African American church attendees. Transfusion 2011; 51: 158-65.
35. Shaz BH, Hillyer CD,. Minority donation in the United States: challenges and needs. Curr Opin Hematol 2010; 17: 544-9.
36. Kacker S, Ness PM, Savage WJ, et al., Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion 2014; 54: 2034-44.